In the following white paper, Worldwide Clinical Trials’ chief medical and scientific officer, Michael Murphy, M.D., Ph.D., and assistant director, clinical research methodology, William Slone, Ph.D., discuss when, how, and whether to factor external controls into a program.

Meet Lona Sheeran, Senior Vice President of Early Phase Clinical Operations at Worldwide Clinical Trials. With over 20 years operating in early phase environment, Lona has a track record of driving organizational and financial excellence.

In the following Journal for Clinical Studies article, Worldwide Clinical Trials’ chief medical and scientific officer, Dr. Michael Murphy and senior vice president of project planning and administration, Ted Finlan, discuss how to successfully manage the increasing amounts of data generated during a study.

Why does Worldwide celebrate Heart Month? Learn this and more in our latest podcast featuring Cardiovascular and Metabolic Therapeutic Leader Karen Hill and Project Manager Kim Sydes.

As new laws and innovative technologies emerge, regulatory pathways in global markets are becoming increasingly more difficult to navigate. Aman Khera, Head of Global Regulatory Strategy at Worldwide Clinical Trials, discusses some trends she anticipates might impact the regulatory landscape in 2020.

Worldwide has been chosen as one of Pharma Tech Outlook’s Top 10 Bioanalytical Services Companies of 2019. Read more in the following cover story.